Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VNQ vs GSK✓SelectedUSD · GSKVNQ vs GSK performance historyLatest closeAs of-1.39%11/17
Stock and ETF performance explorer

VNQ vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+4.7%
GSK return
+43.9%
Excess return
-39.2%
Maximum drawdown
-34.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.4%-2.3%+0.9%-0.8%
7D-2.3%-3.0%+0.8%-1.5%
30D+3.4%+0.4%+3.1%+3.3%
3M-2.3%-1.2%-1.1%-2.2%
6M+2.8%+0.9%+1.9%+2.4%
YTD+10.3%+4.0%+6.3%+8.6%
1Y+10.8%+7.3%+3.5%+8.3%
3Y+34.9%+57.1%-22.2%+17.1%
5Y+4.7%+43.0%-38.2%-11.9%
All+4.7%+43.9%-39.2%-11.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling